KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling

[1]  E. Lalli,et al.  Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. , 2012, Endocrinology.

[2]  M. Bäckdahl,et al.  Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter , 2012, PloS one.

[3]  C. Meisinger,et al.  Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. , 2012, European journal of endocrinology.

[4]  R. Bollag,et al.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  D. Bayliss,et al.  TASK-3 Channel Deletion in Mice Recapitulates Low-Renin Essential Hypertension , 2012, Hypertension.

[6]  F. Veglio,et al.  Visinin-Like 1 Is Upregulated in Aldosterone-Producing Adenomas With KCNJ5 Mutations and Protects From Calcium-Induced Apoptosis , 2012, Hypertension.

[7]  Morris J. Brown,et al.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. , 2012, The Journal of clinical endocrinology and metabolism.

[8]  F. Beuschlein,et al.  Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism , 2012, Hypertension.

[9]  Morris J. Brown,et al.  Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas , 2012, Hypertension.

[10]  C. Gomez-Sanchez,et al.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. , 2012, Endocrinology.

[11]  T. Strom,et al.  KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism , 2012, Hypertension.

[12]  R. Lifton,et al.  Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5 , 2012, Proceedings of the National Academy of Sciences.

[13]  M. Mori,et al.  Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  M. Sibony,et al.  Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. , 2011, Endocrinology.

[15]  S. Mane,et al.  K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension , 2011, Science.

[16]  X. Jeunemaître,et al.  Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism , 2010, HYPERTENSION.

[17]  J. Barhanin,et al.  TASK1 and TASK3 Potassium Channels: Determinants of Aldosterone Secretion and Adrenocortical Zonation , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  E. Letavernier,et al.  Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma , 2008, Journal of hypertension.

[19]  R. Lifton,et al.  A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  P. Bernante,et al.  Heterogeneity of Aldosterone-Producing Adenomas Revealed by a Whole Transcriptome Analysis , 2007, Hypertension.

[21]  D. Calhoun,et al.  Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension , 2002, Hypertension.

[22]  H. Sasano.  Localization of steroidogenic enzymes in adrenal cortex and its disorders. , 1994, Endocrine journal.

[23]  K. Nakagawa,et al.  Adrenocortical zonation in humans under normal and pathological conditions. , 2010, The Journal of clinical endocrinology and metabolism.